{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:36:35Z","timestamp":1793046995727,"version":"4.5.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1097\/ftd.0b013e31827318b8","type":"journal-article","created":{"date-parts":[[2012,11,3]],"date-time":"2012-11-03T09:25:24Z","timestamp":1351934724000},"page":"729-735","source":"Crossref","is-referenced-by-count":32,"title":["Detection and Validated Quantification of the Phosphodiesterase Type 5 Inhibitors Sildenafil, Vardenafil, Tadalafil, and 2 of Their Metabolites in Human Blood Plasma by LC-MS\/MS\u2500Application to Forensic and Therapeutic Drug Monitoring Cases"],"prefix":"10.1097","volume":"34","author":[{"given":"Kristina Y.","family":"Rust","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrike","family":"Wilkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Bregel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Wilske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kraemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210129","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1177\/0091270005276847","article-title":"The clinical pharmacokinetics of phosphodiesterase-5 inhibitors for erectile dysfunction.","volume":"45","author":"Gupta","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"R2-14-20210129","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1183\/09031936.00124007","article-title":". Phosphodiesterase inhibitors for the treatment of pulmonary hypertension.","volume":"32","author":"Wilkins","year":"2008","journal-title":"Eur Respir J"},{"key":"R3-14-20210129","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00216-010-3958-3","article-title":"Anabolic, doping, and lifestyle drugs, and selected metabolites in wastewaterdetection, quantification, and behaviour monitored by high-resolution MS and MS(n) before and after sewage treatment.","volume":"398","author":"Schroder","year":"2010","journal-title":"Anal Bioanal Chem"},{"key":"R4-14-20210129","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/rcm.4568","article-title":"Anzillotti L, de lT X, et al.. A gas chromatographymass spectrometry method for the determination of sildenafil, vardenafil and tadalafil and their metabolites in human urine.","volume":"24","author":"Strano-Rossi","year":"2010","journal-title":"Rapid Commun Mass Spectrom"},{"key":"R5-14-20210129","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/bmc.1181","article-title":". Development of a method for the determination of vardenafil in human plasma by high performance liquid chromatography with UV detection.","volume":"23","author":"Carlucci","year":"2009","journal-title":"Biomed Chromatogr"},{"key":"R6-14-20210129","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jchromb.2007.01.049","article-title":". Validated liquid chromatographic-ultraviolet method for the quantitation of tadalafil in human plasma using liquid-liquid extraction.","volume":"852","author":"Shakya","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R7-14-20210129","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jpba.2009.05.022","article-title":". High performance liquid chromatography-diode array and electrospray-mass spectrometry analysis of vardenafil, sildenafil, tadalafil, testosterone and local anesthetics in cosmetic creams sold on the Internet web sites.","volume":"50","author":"De","year":"2009","journal-title":"J Pharm Biomed Anal"},{"key":"R8-14-20210129","doi-asserted-by":"crossref","first-page":"982186","DOI":"10.1155\/2011\/982186","article-title":". A high-performance liquid chromatography:chemiluminescence method for potential determination of vardenafil in dietary supplement.","volume":"2011","author":"Di","year":"2011","journal-title":"J Autom Methods Manag Chem"},{"key":"R9-14-20210129","doi-asserted-by":"crossref","first-page":"8426","DOI":"10.1016\/j.chroma.2009.10.016","article-title":". Identification of sildenafil, tadalafil and vardenafil by gas chromatography-mass spectrometry on short capillary column.","volume":"1216","author":"Man","year":"2009","journal-title":"J Chromatogr A"},{"key":"R10-14-20210129","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/jms.1868","article-title":". A fully validated method for the determination of vardenafil in blood using gas chromatographymass spectrometry.","volume":"46","author":"Papoutsis","year":"2011","journal-title":"J Mass Spectrom"},{"key":"R11-14-20210129","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jhazmat.2011.04.058","article-title":". Synthesis of core-shell magnetic molecularly imprinted polymers and detection of sildenafil and vardenafil in herbal dietary supplements.","volume":"191","author":"Ding","year":"2011","journal-title":"J Hazard Mater"},{"key":"R12-14-20210129","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jpba.2010.09.022","article-title":". Separation and structural elucidation of a novel analogue of vardenafil included as an adulterant in a dietary supplement by liquid chromatography-electrospray ionization mass spectrometry, infrared spectroscopy and nuclear magnetic resonance spectroscopy.","volume":"54","author":"Lee","year":"2011","journal-title":"J Pharm Biomed Anal"},{"key":"R13-14-20210129","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jpba.2007.04.011","article-title":"Use of liquid chromatography-mass spectrometry and a chemical cleavage reaction for the structure elucidation of a new sildenafil analogue detected as an adulterant in an herbal dietary supplement.","volume":"44","author":"Reepmeyer","year":"2007","journal-title":"J Pharm Biomed Anal"},{"key":"R14-14-20210129","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/jssc.200900841","article-title":". Simultaneous determination of yohimbine, sildenafil, vardenafil and tadalafil in dietary supplements using high-performance liquid chromatography-tandem mass spectrometry.","volume":"33","author":"Zhang","year":"2010","journal-title":"J Sep Sci"},{"key":"R15-14-20210129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.forsciint.2011.07.052","article-title":". Detection and validated quantification of 21 benzodiazepines and 3 z-drugs in human hair by LC-MSMS.","volume":"215","author":"Rust","year":"2012","journal-title":"Forensic Sci Int"},{"key":"R17-14-20210129","first-page":"185","article-title":". Anhang B zur Richtlinie der GTFCh zur Qualitatssicherung bei forensisch-toxikologischen Untersuchungen. Toxichem.","volume":"76","author":"Peters","year":"2009","journal-title":"Krimtech"},{"key":"R19-14-20210129","first-page":"8","article-title":"Recommendations from the Society for Toxicological and Forensic Chemistry (GTFCh) concerning the validation of methods for toxicological analysis in the context of determining brain death.","volume":"35","author":"Peters","year":"2005","journal-title":"TIAFT Bull"},{"key":"R20-14-20210129","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1023\/A:1015829422034","article-title":". Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report.","volume":"9","author":"Shah","year":"1992","journal-title":"Pharm Res"},{"key":"R21-14-20210129","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1373\/clinchem.2009.135517","article-title":"Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine.","volume":"56","author":"Meyer","year":"2010","journal-title":"Clin Chem"},{"key":"R22-14-20210129","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/jms.1191","article-title":". Detection and validated quantification of toxic alkaloids in human blood plasmacomparison of LC-APCI-MS with LC-ESI-MSMS.","volume":"42","author":"Beyer","year":"2007","journal-title":"J Mass Spectrom"},{"key":"R23-14-20210129","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0090-9556(24)15055-6","article-title":". In vitro biotransformation of sildenafil (Viagra): identification of human cytochromes and potential drug interactions.","volume":"28","author":"Warrington","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"R24-14-20210129","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00007691-200404000-00019","article-title":"Genetics of the variable expression of CYP3A in humans.","volume":"26","author":"Wojnowski","year":"2004","journal-title":"Ther Drug Monit"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e31827318b8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T05:28:32Z","timestamp":1745126912000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201212000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e31827318b8","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}